OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Cold injections can be uncomfortable
In in vitro inflammatory models, this tripeptide consistently downregulates the expression of pro-inflammatory cytokines, allowing researchers to study cellular homeostasis and immune pathway modulation
Store Glutathione nasal spray according to the instructions provided with the product, and keep it out of reach of children and pets
This gives me the right amount of jitters and drive to get through my workout
All products are tested for safety and efficacy, but scent preferences are personal and subjective